Eliem Therapeutics, Inc. (ELYM)
NASDAQ: ELYM · IEX Real-Time Price · USD
7.74
+0.44 (6.03%)
Jul 22, 2024, 10:11 AM EDT - Market open
Eliem Therapeutics Employees
As of December 31, 2023, Eliem Therapeutics had 11 total employees, including 9 full-time and 2 part-time employees. The number of employees decreased by 32 or -74.42% compared to the previous year.
Employees
11
Change (1Y)
-32
Growth (1Y)
-74.42%
Revenue / Employee
n/a
Profits / Employee
-$1,320,545
Market Cap
518.25M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 11 | -32 | -74.42% |
| Dec 31, 2022 | 43 | 12 | 38.71% |
| Dec 31, 2021 | 31 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Enhabit | 10,800 |
| Treace Medical Concepts | 516 |
| Jin Medical International | 245 |
| biote | 194 |
| Fate Therapeutics | 181 |
| Heron Therapeutics | 126 |
| Fulcrum Therapeutics | 76 |
| Oculis Holding AG | 36 |
ELYM News
- 24 days ago - Eliem Therapeutics Announces its Addition to the Russell 2000® and Russell 3000® Indexes - GlobeNewsWire
- 24 days ago - Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement - GlobeNewsWire
- 3 months ago - SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Eliem Therapeutics, Inc. (ELYM) and Encourages Investors to Contact the Firm - PRNewsWire
- 3 months ago - ELYM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Eliem Therapeutics, Inc. Is Fair to Shareholders - Business Wire
- 3 months ago - Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement - GlobeNewsWire
- 1 year ago - Eliem Therapeutics' stock soars 21% premarket after company says it may sell itself - Market Watch
- 1 year ago - Eliem Therapeutics Announces Plans to Explore Strategic Alternatives - GlobeNewsWire
- 1 year ago - Eliem Therapeutics Reports First Quarter Financial Results and Business Highlights - GlobeNewsWire